Literature DB >> 15367673

Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family.

Viola Calabrò1, Gelsomina Mansueto, Raffaela Santoro, Antonio Gentilella, Alessandra Pollice, Pamela Ghioni, Luisa Guerrini, Girolama La Mantia.   

Abstract

The ARF/MDM2/p53 pathway is a principal defense mechanism to protect the organism from uncontrolled effects of deregulated oncogenes. Oncogenes activate ARF, which interacts with and inhibits the ubiquitin ligase MDM2, resulting in p53 stabilization and activation. Once stabilized and activated, p53 can either induce or repress a wide array of different gene targets, which in turn can regulate cell cycle, DNA repair, and a number of apoptosis-related genes. Here we show that, unlike p53, p63, a member of the p53 family, directly interacts with p14(ARF). Through this interaction ARF inhibits p63-mediated transactivation and transrepression. In p63-transfected cells, ARF, which normally localizes into nucleoli, accumulates in the nucleoplasm. Based on these observations, we suggest that stimuli inducing p14(ARF) expression can, at the same time, activate p53 and impair p63 transcriptional activity, altering the pattern of p53 target gene expression. Here we show, for the first time, a physical and functional link between the p14(ARF) tumor suppressor protein and p63, a member of the p53 family.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15367673      PMCID: PMC516740          DOI: 10.1128/MCB.24.19.8529-8540.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  p53 Family members p63 and p73 are SAM domain-containing proteins.

Authors:  C D Thanos; J U Bowie
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

Review 2.  The regulation of APAF1 expression during development and tumourigenesis.

Authors:  E S Hickman; K Helin
Journal:  Apoptosis       Date:  2002-04       Impact factor: 4.677

3.  The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein.

Authors:  M Vivo; R A Calogero; F Sansone; V Calabrò; T Parisi; L Borrelli; S Saviozzi; G La Mantia
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

4.  p53-independent functions of the p19(ARF) tumor suppressor.

Authors:  J D Weber; J R Jeffers; J E Rehg; D H Randle; G Lozano; M F Roussel; C J Sherr; G P Zambetti
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

5.  The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the p53 homolog p63.

Authors:  Viola Calabrò; Gelsomina Mansueto; Tiziana Parisi; Maria Vivo; Raffaele A Calogero; Girolama La Mantia
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

6.  Human ARF binds E2F1 and inhibits its transcriptional activity.

Authors:  B Eymin; L Karayan; P Séité; C Brambilla; E Brambilla; C J Larsen; S Gazzéri
Journal:  Oncogene       Date:  2001-03-01       Impact factor: 9.867

Review 7.  On the shoulders of giants: p63, p73 and the rise of p53.

Authors:  Annie Yang; Mourad Kaghad; Daniel Caput; Frank McKeon
Journal:  Trends Genet       Date:  2002-02       Impact factor: 11.639

8.  p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.

Authors:  M Dohn; S Zhang; X Chen
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

9.  Apaf-1 is a transcriptional target for E2F and p53.

Authors:  M C Moroni; E S Hickman; E Lazzerini Denchi; G Caprara; E Colli; F Cecconi; H Müller; K Helin
Journal:  Nat Cell Biol       Date:  2001-06       Impact factor: 28.824

10.  Down-regulation of p63 is required for epidermal UV-B-induced apoptosis.

Authors:  K M Liefer; M I Koster; X J Wang; A Yang; F McKeon; D R Roop
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

View more
  8 in total

Review 1.  Dlx genes, p63, and ectodermal dysplasias.

Authors:  Maria I Morasso; Nadezda Radoja
Journal:  Birth Defects Res C Embryo Today       Date:  2005-09

Review 2.  Translating p53 into the clinic.

Authors:  Chit Fang Cheok; Chandra S Verma; José Baselga; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2010-10-26       Impact factor: 66.675

Review 3.  Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.

Authors:  Alexander H Stegh
Journal:  Expert Opin Ther Targets       Date:  2012-01-12       Impact factor: 6.902

4.  Androgen receptor drives cellular senescence.

Authors:  Yelena Mirochnik; Dorina Veliceasa; Latanya Williams; Kelly Maxwell; Alexander Yemelyanov; Irina Budunova; Olga V Volpert
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function.

Authors:  Zijun Y Xu-Monette; Shanxiang Zhang; Xin Li; Ganiraju C Manyam; Xiao-Xiao Wang; Yi Xia; Carlo Visco; Alexandar Tzankov; Li Zhang; Santiago Montes-Moreno; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Xiaoying Zhao; Michael B Møller; Ben M Parsons; Jane N Winter; Miguel A Piris; L Jeffrey Medeiros; Ken H Young
Journal:  Aging (Albany NY)       Date:  2016-02       Impact factor: 5.682

Review 6.  Epigenetic Regulation of Epidermal Stem Cell Biomarkers and Their Role in Wound Healing.

Authors:  Sabita N Saldanha; Kendra J Royston; Neha Udayakumar; Trygve O Tollefsbol
Journal:  Int J Mol Sci       Date:  2015-12-24       Impact factor: 5.923

7.  Methylation profiling identifies two subclasses of squamous cell carcinoma related to distinct cells of origin.

Authors:  Manuel Rodríguez-Paredes; Felix Bormann; Günter Raddatz; Julian Gutekunst; Carlota Lucena-Porcel; Florian Köhler; Elisabeth Wurzer; Katrin Schmidt; Stefan Gallinat; Horst Wenck; Joachim Röwert-Huber; Evgeniya Denisova; Lars Feuerbach; Jeongbin Park; Benedikt Brors; Esther Herpel; Ingo Nindl; Thomas G Hofmann; Marc Winnefeld; Frank Lyko
Journal:  Nat Commun       Date:  2018-02-08       Impact factor: 14.919

Review 8.  Dual Role of the Alternative Reading Frame ARF Protein in Cancer.

Authors:  Rosa Fontana; Michela Ranieri; Girolama La Mantia; Maria Vivo
Journal:  Biomolecules       Date:  2019-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.